RecruitingNCT06519162

Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome

Exploration of Liver-gut Axis Through Identification of Liver Disease-specific Microbiome

Sponsor

Chungnam National University Hospital

Enrollment

3,000 participants

Start Date

Jul 8, 2024

Study Type

OBSERVATIONAL

Conditions

Non-Alcoholic Fatty Liver Disease Autoimmune Hepatitis Primary Sclerosing Cholangitis Primary Biliary Cirrhosis Liver Abscess

Summary

In this study, we aim to identify gut microbiomes specific to patients with chronic refractory liver disease and to conduct a gut-liver axis study on the pathogenesis and disease progression.

Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with autoimmune hepatitis, liver abscess, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 19 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.